Abstract: A process is described for reducing the NOx concentration and N2O concentration from the residual gas from nitric acid production. The process encompasses the passing of the residual gas leaving the absorption column, prior to entry into the residual gas turbine, through a combination of two stages. The first stage here reduces the NOx content and the second stage the N2O content of the gas, the NOx/N2O ratio prior to entry of the gas into the second stage being in the range from 0.001 to 0.5, and this gas being brought into contact in the second stage with a catalyst which is substantially composed of one or more iron-loaded zeolites.

Abstract: Disclosed is a process for treating wastes discharged from an acrylic acid production process and a consecutive polyacrylic acid production process in which at least one waste selected from the group consisting of waste oil, waste water, and waste gas from said acrylic acid production process, and waste water and/or waste gas from said polyacrylic acid production process are combusted simultaneously.

Abstract: The present invention describes an additive which controls stickies formation and removes anionic trash from recycled old corrugated container furnish, old newsprint furnish, deinked pulp furnish, old magazine grade furnish, coated broke furnish, or thermomechanical pulp furnish. The present invention treats talc with either a tertiary or quaternary amine. The treated talc is then added to the pulp slurry and removes stickies by binding the stickies to the talc and neutralizes the anionic trash that may be present.

Abstract: A method of purifying lithium hexafluorophosphate that allows to purify lithium hexafluorophosphate, useful as lithium secondary cell electrolyte, organic synthesis medium or the like, to an extremely high purity is provided. Lithium hexafluorophosphate containing harmful impurities such as oxyfluoride, lithium fluoride is purified by adding phosphoric chloride. The purification is performed in the presence of phosphoric chloride and hydrogen fluoride of the quantity equal or superior to the equivalent amount for reacting them, and then by converting lithium fluoride lithium hexafluorophosphate with generated phosphor pentafluoride.

Abstract: A process is provided for the separation of ammonia (I) from mixtures (II) containing ammonia (I) and an amide (IV) selected from the group consisting of a lactam (IVa), an oligomer (IVb) and a polymer (IVc) with amide groups in the main chain, said amide (IV) having been obtained by reacting educts (III), selected from the group consisting of nitrites (IIIa), amines (IIIb), amino nitrites (IIIc) and amino amides (IIId), with water, wherein

Abstract: The invention relates to a method for producing shaped inorganic cyanide bodies, especially made of alkaline metal cyanides and alkaline earth metal cyanides, by pressing particulate inorganic cyanide obtained by means of a crystallization method. According to the invention, a cyanide crystallate separated from a mother liquor by means of a solid-liquid separation device and containing 2-15 wt. % water is fed to a forming device without the addition of an auxiliary forming agent and placed under pressure and compressed to form shaped bodies containing 0.1-12 wt. % water. The amount of water contained by the shaped bodies is always less than that contained in the crystallates used for the production thereof. Preferably, the crystallite is pressed out of a rotary filter or a centrifuge at a temperature of more than 40° C. to form shaped bodies containing 0.2-6 wt. % residual water. The inventive method can be carried out in a more economical manner than previously known methods using dried cyanide.

Abstract: The invention relates to a process for the production of nitric acid of a concentration ranging from 68 to 76% by wt., using the mono-pressure or the dual-pressure process in which the ammonia feedstock is combusted with the aid of compressed process air. The water vapour content of the process air used for combustion and/or stripping and imported from outside the system, is reduced in this process.

Abstract: A process is described for recovering sodium carbonate or other sodium-based chemicals from sodium-bearing streams, including in particular mine water, evaporative pond water and sodium carbonate decahydrate deposits, recycle and purge streams, and other waste streams. In the process selected sodium bicarbonate-bearing streams are decarbonized to reduce the sodium bicarbonate concentration in a combination with other sodium-bearing streams, resulting in a liquor suitable as feed to a sodium carbonate decahydrate or sodium carbonate monohydrate process. The sodium bicarbonate concentration can be reduced using any number of known processes such as reacting said sodium bicarbonate with a neutralizing agent such as calcium oxide, calcium hydroxide, sodium hydroxide, or other alkali. Sodium bicarbonate can also be stripped using steam or air.

Abstract: The present invention is directed to a method for changing the color of colored natural diamonds. The method includes placing a discolored natural diamond in a pressure-transmitting medium which is consolidated into a pill. Next, the pill is placed into a high pressure/high temperature (HP/HT) press at elevated pressure and elevated temperature for a time sufficient to improve the color of the diamond. The diamond may be exposed at elevated-pressure and elevated-temperature conditions within the graphite-stable region of the carbon-phase diagram—without significant graphitization of the diamond, or above the diamond-graphite equilibrium and within the diamond-stable region of the carbon-phase diagram. Finally, the diamond is recovered from said press. Colorless Type Ia and Type II diamonds may be made by this method.

Abstract: The present invention provides a combustion apparatus for the production of carbon nanomaterials including fullerenes and fullerenic soot. Most generally the combustion apparatus comprises one or more inlets for introducing an oxygen-containing gas and a hydrocarbon fuel gas in the combustion system such that a flame can be established from the mixed gases, a droplet delivery apparatus for introducing droplets of a liquid hydrocarbon feedstock into the flame, and a collector apparatus for collecting condensable products containing carbon nanomaterials that are generated in the combustion system. The combustion system optionally has a reaction zone downstream of the flame. If this reaction zone is present the hydrocarbon feedstock can be introduced into the flame, the reaction zone or both.

Abstract: A new process for recovery of Low Sodium Salt from bittern has been described in the present invention, the said process comprising desulphatation of bittern (by-product of salt industry), evaporation of bittern in solar pans and processing of solid mixture with water to produce a mixture of sodium and potassium chlorides and optionally preparing “free flowing” and iodized, by known techniques.

Abstract: A process and apparatus for the synthesis of metal oxide nanopowder from a metal compound vapour is presented. In particular a process and apparatus for the synthesis of TiO2 nanopowder from TiCl4 is disclosed. The metal compound vapour is reacted with an oxidizing gas in electrically induced RF frequency plasma thus forming a metal oxide vapour. The metal oxide vapour is rapidly cooled using a highly turbulent gas quench zone which quickly halts the particle growth process, yielding a substantial reduction in the size of metal oxide particles formed compared with known processes. The metal compound vapour can also react with a doping agent to create a doped metal oxide nanopowder. Additionally, a process and apparatus for the inline synthesis of a coated metal oxide is disclosed wherein the metal oxide particles are coated with a surface agent after being cooled in a highly turbulent gas quench zone.

Abstract: A method is disclosed for directly preparing alkali metal aluminum hydrides such as NaAlH4 and Na3AlH6 from either the alkali metal or its hydride, and aluminum. The hydride thus prepared is doped with a small portion of a transition metal catalyst compound, such as TiCl3, TiF3, or a mixture of these materials, in order to render them reversibly hydridable. The process provides for mechanically mixing the dry reagents under an inert atmosphere followed by charging the mixed materials with high pressure hydrogen while heating the mixture to about 125° C. The method is relatively simple and inexpensive and provides reversible hydride compounds which are free of the usual contamination introduced by prior art wet chemical methods.

Abstract: The process for producing hydrogen gas according to the present invention consists of reacting aluminum with water in the presence of sodium hydroxide as a catalyst. In one aspect of the present invention, there is provided a process for producing hydrogen gas, comprising the steps of: providing an aqueous solution containing between 0.26 M and 19 M NaOH in a vessel. The next step consists of reacting aluminum with water at the surface of the solution to generate a region of effervescence at the surface of the solution and a precipitate sinking from the region of effervescence to the bottom of the vessel. The region of effervescence is kept separated from the precipitate at the bottom the vessel, to prevent any precipitate from mixing with the aluminum therein.

Abstract: The present invention relates to a supported catalyst system. The supported catalyst of the present invention comprises an inorganic support having attached to at least one surface thereof non-acidic, hydrophillic, hydroxyl-containing organic R10 groups having no or substantially no surface charge in solution, and at least one linker capable of binding a catalytic species, e.g. an enzyme or an organometallic molecule, wherein the linker is attached to a catalytic species. The R10 groups preferably are selected from the group consisting of —CH2OH, —CH(OH)2, —CH(OH)CH3, —CH2CH2OH, —CH(OH)2CH3, —CH2CH(OH)2, —CH(OH)CH2(OH) and mixtures thereof. The presence of the R10 groups on the support surface prevents or reduces non-specific binding of the catalytic species with the support surface by minimizing hydrophobic interactions and providing no or substantially no surface charge in the region of the support having catalytic species attached thereto.

Abstract: A method of treating tumors, such as prostate tumors, breast tumors, non-Hodgkin's lymphoma, and the like, includes the sequential steps of administering to the patient at least one dose of an antiangiogenic cyclo-arginine-glycine-aspartic acid-containing pentapeptide (cRGD pentapeptide); administering to the patient an anti-tumor effective amount of a radioimmunotherapeutic agent (RIT); and then administering to the patient at least one additional dose of cRGD pentapeptide. The cRGD pentapeptide is preferably cyclo-(Arg-Gly-Asp-D-Phe-[N-Me]-Val), and the RIT is preferably a radionuclide-labeled chelating agent-ligand complex in which chelating agent is chemically bonded to a tumor-targeting molecule, such as a monoclonal antibody.

Abstract: The present invention provides binding moieties for fibrin which have a variety of uses wherever detecting, isolating or localizing fibrin, and particularly fibrin as opposed to fibrinogen, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding fibrin and recognizing the form of polymerized fibrin found in thrombi. In addition, the polypeptides have a slow dissociation rate from fibrin, which improves their ability to form a contrast image at the site of a fibrin clot, making the disclosed binding moieties particularly useful as imaging agents for thrombi.

Abstract: Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The conjugates include several cyanine dyes with a variety of bis- and tetrakis (carboxylic acid) homologues. The compounds may be conjugated to bioactive peptides, carbohydrates, hormones, drugs, or other bioactive agents. The small size of the compounds allows more favorable delivery to tumor cells as compared to larger molecular weight imaging agents. The various dyes are useful over the range of 350-1300 nm, the exact range being dependent upon the particular dye. Use of dimethylsulfoxide helps to maintain the fluorescence of the compounds. The inventive compounds are useful for diagnostic imaging and therapy, in endoscopic applications for the detection of tumors and other abnormalities, for localized therapy, for photoacoustic tumor imaging, detection and therapy, and for sonofluorescence tumor imaging, detection and therapy.

Abstract: Methods and compositions for detecting and localizing light originating from a mammal are disclosed. Also disclosed are methods for targeting light emission to selected regions, as well as for tracking entities within the mammal. In addition, animal models for disease states are disclosed, as are methods for localizing and tracking the progression of disease or a pathogen within the animal, and for screening putative therapeutic compounds effective to inhibit the disease or pathogen.

Abstract: A medicinal preparation capable of lowering the threshold of cavitation and generating active oxygen species via acoustic cavitation caused by an ultrasound is provided. The preparation, which is to be used in combination with ultrasonic irradiation, comprises a shell within the internal space of which a gas is enclosed and which contains or retains a substance capable of generating active oxygen species upon ultrasonic irradiation of the shell.

Abstract: A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.

Abstract: This invention relates to aerosol formulations of use for the administration of medicaments by inhalation, in particular a pharmaceutical aerosol formulation which comprises particulate salbutamol and physiologically acceptable salts and solvates thereof and a fluorocarbon or hydrogen-containing chlorofluorocarbon propellant, which formulation is substantially free of surfactant. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of a pharmaceutical aerosol formulation as defined is also described.

Abstract: A reductant rinse including xylitol prevents buildup in ozone carrying lines in apparatus for the treatment of dental caries.

Abstract: Disclosed herein are chemopreventive methods and topical formulations for the prevention and treatment of ultraviolet light-induced skin cancers, pre-cancerous lesions, and hyperproliferative disorders in mammals, such as humans, utilizing doses of non-steroidal anti-inflammatory drugs. Low doses of non-steroidal anti-inflammatory drugs are present in the topical formulations and allow continued regular use over an extended period of time to prevent such disorders. In particular, the present invention is particularly suitable for non-melanoma skin cancers as these cancers tend to appear in areas of the skin that have had excess sun exposure (head, neck and arms) meaning that the chemopreventive agent would not need to be applied over the entire body of the typical patient. Moreover, it is possible to identify “high-risk” individuals within the populations because people who report one episode of NMSC tend to have a high incidence of a subsequent episode.

Abstract: The invention relates to aqueous dispersions of sparingly water-soluble or water-insoluble organic UV filter substances, which comprise at least one sparingly water-soluble or water-insoluble organic UV filter substance as colloidally disperse phase in amorphous or partially amorphous form.

Abstract: The invention relates to the use of vitamin B6 derivatives, preferably pyridoxine, pyridoxal, pyridoxal-5′-phosphate and pyridoxamine for prevention of damage to keratin fibres.

Abstract: Compositions comprising at least one PEG fatty acid diester and at least one salt of a fatty acid gelling agent wherein the at least one PEG fatty acid diester and the at least one salt of a fatty acid gelling agent are present in an amount effective to provide a stable composition, and methods for using the same.

Abstract: A product for application to skin includes a container having an open end, a non-flowable composition within the container including an application surface at the open end having a visual pattern, and a removable cap having a % opacity of less than 5%.

Abstract: The subject-matter of the present invention is a stable anhydrous composition-for cosmetic or pharmaceutical use comprising at least one silicone oil and at least one pigment, wherein said composition further comprises at least one oxyalkylenated silicone substituted at the &agr;and &ohgr; positions.

Abstract: A cosmetic which includes from about one to about ten parts ethyl cellulose, from about one to about ten parts of a cosmetic pigment, from about 70 to about 95 parts of an organic solvent, and from about one to about ten parts of an alcohol soluble and water insoluble resin. The resin is a polymer which includes one or more of the following monomers: octylacrylamide, acrylate, butylaminoethyl methacrylate, and methyl methacrylate, hydroxypropyl methacrylate, polyvinyl acetate.

Abstract: The object of the present invention is to provide a hair treatment having high dechlorinating and hydroxy radical-scavenging abilities, excellent safety to skin, low irritation and sufficiently high storage stability required in view of the production of preparations, and provide a hair care composition using the hair treatment agent.

Abstract: Compositions and methods for treating keratin-related conditions and disorders such as straightening and styling hair, treating nail fungal conditions such as onychomycosis, ingrown nails, and hyperkeratotic conditions of the epidermis such as psoriasis, acne, callouses, corns, verruca, particularly plantar warts, and surface lines and blemishes of aging skin by aiding the exfoliation of keratinocytes. The compositions comprise at least one alkanoic acid in aqueous solution.

Abstract: The compositions of the present invention relate to improved shampoo compositions having from about from about 5 to about 50 weight percent of a detersive surfactant, at least about 0.05 weight percent of a polyalkylene oxide alkyl ether selected from the group consisting of polyethylene glycol alkyl ethers, polypropylene glycol alkyl ethers, polyethylene glycol polypropylene glycol alkyl ethers, and combinations thereof, and at least about 20.0 weight percent of an aqueous carrier; wherein the polyalkylene oxide alkyl ether has an HLB of less than 10.

Abstract: Cosmetic compositions comprising at least two polymers comprising complementary chemical functional groups, capable of forming a coat on a keratin material, such as hair, a cosmetic process comprising the use of these polymers on the keratin material, such as the hair, and also their use for producing a coat on the hair.

Abstract: Silicone oil-in-water emulsions are prepared using a silicone polyether as the surfactant, and the silicone oil-in-water emulsions are stable in an aqueous media in the presence of salts such as electrolytes, alcohols, solvents, and combinations thereof. The silicone oil-in-water emulsions are prepared by (i) polymerizing silicon atom containing monomers in water containing the monomer, a silicone polyether, a catalyst, and optionally an organic surfactant(s), until a silicone oil of a desired molecular weight is obtained. The silicone oil-in-water emulsions possess utility as additives in various coating products, personal care products, household care products, automotive care products, and petroleum products.

Abstract: The compositions of the present invention relate to improved shampoo compositions having from about from about 5 to about 50 weight percent of a detersive surfactant, at least about 0.05 weight percent of a silicone in water emulsion made by mixing materials comprising (I) a composition containing at least one first polysiloxane having at least one Si—H group, at least one second polysiloxane having at least one aliphatically unsaturated group that reacts with said first polysiloxane by a chain extension reaction and a metal containing catalyst for said chain extension reaction, (II) at least one surfactant selected from the group consisting of anionic, cationic, alkylpolysaccharide and amphoteric, and (III) water to form a mixture; and emulsifying the mixture; and at least about 20.0 weight percent of an aqueous carrier.

Abstract: Disclosed is a hair conditioning composition for applying to the dry hair prior to washing the hair, comprising by weight: (a) from about 30% to about 99.9% of a conditioning oil which is in liquid form at 25° C.; and (b) a thickener in an amount which provides the composition to have a viscosity of from about 500 mPa·s to about 200,000 mPa·s, the thickener selected from the group consisting of fatty compounds, waxy compounds, gelling agents, inorganic thickeners, oil soluble polymers, and mixtures thereof.

Abstract: The present invention is directed to the use of xanthan gum, particularly heat treated xanthan gum, as a fixative in hair cosmetic compositions. Xanthan gum is advantageous in that it may be used with other hair fixatives and provides rheology modifying and other properties including excellent stiffness, gloss, dry comb, wet comb, non-flake, anti-static, feel and high humidity curl retention.

Abstract: The invention relates to a styling composition comprising, in a physiologically acceptable liquid medium, the combination of at least one film-forming fixing polymer and of at least one crystalline hot-melt polymer which is soluble in the said medium and which has a crystalline melting temperature, measured by differential scanning calorimetry, of between 30° C. and 80° C., and to a process for the thermal remodelling of the hair using this composition.

Abstract: The invention relates to the use of nanoscalar, cationic compounds with particle diameters of between 10 and 300 nm for producing cosmetic and/or pharmaceutical preparations.

Abstract: The present invention relates to a method of removing organic acid an/or organic amines odors from aqueous systems by treating the aqueous system or the atmosphere adjacent to the aqueous system with a solution of a substantially sulfonate free, anionic kraft pine lignin.

Abstract: Methods and uses for treatment of dyslipidemia comprising administration of a GLP-1 compound and another antidyslipidemic drug.

Abstract: The invention is directed to a biocompatible stable composition containing a hydrophobic drug, such as paclitaxel. The composition, which forms a syringeable polymeric micellar solution in aqueous or body fluids, is a freeze-dried product comprising a hydrophobic drug, i.e. paclitaxel, and an amphiphilic block copolymer wherein a hydrophobic group having affinity or attraction with the hydrophobic drug, such as paclitaxel, is incorporated on its end. The invention provides a shelf life of longer than three years in a sterilized container, stability of longer than three days in infusion fluid, has minimal side effects and shows improved bioavailability.

Abstract: The invention provides polymer conjugates of protein kinase C (PKC) inhibitors comprising a polymer, such as poly(ethylene glycol), covalently attached to a PKC inhibitor, such as a bisindolylmaleimide molecule. The linkage between the polymer and the PKC inhibitor is preferably hydrolytically degradable. The invention also includes a pharmaceutical composition comprising a polymer conjugate of a PKC inhibitor and a method of treating any condition responsive to a PKC inhibitor by administering a polymer conjugate of the invention.

Abstract: The present invention relates to compounds having the general formula:

Abstract: The present invention is a method of using a polymeric N-halamine biocidal material as an agent preferably used in conjunction with a matrix material for the reduction of noxious odors caused by the decomposition of organic compounds. In a preferred embodiment of the method according to the present invention, the biocidal N-halamine polymer is provided in a comminuted form and mixed with super absorbent polymer to provide a treatment composition. The treatment composition is emplaced within an article to provide intimate contact between the composition and a microorganism-containing fluid.

Abstract: Methods and compositions are provided comprising ingestibles and a thermochromic composition which is informative as to the temperature history of the ingestible, either prior or contemporaneous with use. Various solid or liquid ingestible compositions are provided for determining storage temperature, temperature of the user, temperature of the ingestible, particularly comestibles, and the like. Of particular interest are polydiacetylene polymers which may be formulated to provide compositions having transition temperature over a broad temperature range.

Abstract: Disclosed are methods and formulations for the treatment of topical conditions on mammalian tissues such as skin and mucous tissues mediated at least in part by viral, bacterial or fungal infections in the mammal. The methods of this invention involve the in situ formation of a polymeric film over the diseased tissue.

Abstract: Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.

Abstract: The present invention relates to novel chemokine polypeptides and encoding nucleic acids. More specifically, therapeutic compositions and methods are provided using isolated nucleic acid molecules encoding a human chemokine beta-1 (Ck&bgr;-1 or Ckb1) polypeptide (previously termed monocyte-colony inhibitory factor (M-CIF), MIP1-&ggr;, and Hemofiltrate CC chemokine-1 (HCC-1)), and Ckb1 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same. Also provided are methods of treating, preventing, ameliorating diseases using such compounds.